RxDoctor Payments Data

William Dalton, MD

Medical Oncology · Baltimore, MDNPI 1124344692

Payments from drug & device makers

$350,077in general payments, 2019–2025

Across 3 payments — averaging $116,692 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$350K
  • Bristol Myers Squibb$61
  • Amgen$16

What the payments were for

  • Food & beverage$77100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie1$350,000
Bristol Myers Squibb1$61
Amgen1$16

How this compares

$350,077 in reported general payments places this provider in the 60th percentile of 180 medical oncology providers in Maryland.

See all medical oncology providers in Maryland

Medicare billing

Part B allowed, 2024
$15,138
Medicare patients
60
Services billed
142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →